This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stemmer, K. Articles by Dietrich, D. R. Search for Related Content PubMed PubMed Citation Articles by Stemmer, K. Articles by Dietrich, D. R.

Carcinogen-Specific Gene Expression Profiles in Short-term Treated Eker and Wild-type Rats Indicative of Pathways Involved in Renal Tumorigenesis

¹ Human and Environmental Toxicology, University of Konstanz, Konstanz, Germany and ² Molecular and Special Toxicology, Bayer Healthcare AG, Wuppertal, Germany

Requests for reprints: Daniel R. Dietrich, Environmental Toxicology, Faculty of Biology, University of Konstanz, Jacob-Burckhardtstrasse 25, D-78457 Konstanz, Germany. Phone: 49-7531-883518; Fax: 49-7531-883170; E-mail: Daniel.Dietrich{at}uni-konstanz.de.

Eker rats heterozygous for a dominant germline mutation in the tuberous sclerosis 2 (Tsc2) tumor suppressor gene were used as a model to study renal carcinogenesis. Eker and corresponding wild-type rats were exposed to genotoxic aristolochic acid (AA) or non-genotoxic ochratoxin A (OTA) to elucidate early carcinogen-specific gene expression changes and to test whether Eker rats are more sensitive to carcinogen-induced changes in gene expression. Male Eker and wild-type rats were gavaged daily with AA (10 mg/kg body weight) or OTA (210 µg/kg body weight). After 1, 3, 7, and 14 days of exposure, renal histopathology, tubular cell proliferation, and Affymetrix gene expression profiles from renal cortex/outer medulla were analyzed. AA-treated Eker and wild-type rats were qualitatively comparable in all variables assessed, suggesting a Tsc2-independent mechanism of action. OTA treatment resulted in slightly increased cortical pathology and significantly elevated cell proliferation in both strains, although Eker rats were more sensitive. Deregulated genes involved in the phosphatidylinositol 3-kinase-AKT-Tsc2-mammalian target of rapamycin signaling, among other important genes prominent in tumorigenesis, in conjunction with the enhanced cell proliferation and presence of preneoplastic lesions suggested involvement of Tsc2 in OTA-mediated toxicity and carcinogenicity, especially as deregulation of genes involved in this pathway was more prominent in the Tsc2 mutant Eker rat. [Cancer Res 2007;67(9):4052–68]

This article has been cited by other articles:

				K. Stemmer, H. Ellinger-Ziegelbauer, H.-J. Ahr, and D. R. Dietrich Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors Am. J. Pathol., October 1, 2009; 175(4): 1686 - 1698. [Abstract] [Full Text] [PDF]

				C. Cavin, T. Delatour, M. Marin-Kuan, F. Fenaille, D. Holzhauser, G. Guignard, C. Bezencon, D. Piguet, V. Parisod, J. Richoz-Payot, et al. Ochratoxin A-Mediated DNA and Protein Damage: Roles of Nitrosative and Oxidative Stresses Toxicol. Sci., July 1, 2009; 110(1): 84 - 94. [Abstract] [Full Text] [PDF]

				M. Adler, K. Muller, E. Rached, W. Dekant, and A. Mally Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity Carcinogenesis, April 1, 2009; 30(4): 711 - 719. [Abstract] [Full Text] [PDF]